Big news in ADPKD research!
Two upcoming RCTs on SGLT2i, aiming to extend #SGLT2i benefits to #ADPKD:
#DAPAPKD, PI @dguerrot & @ecorneclegall:
Total kidney volume evolution over 2y
#STOPPKD, PI @MuellerRom, R.Gansevoort, P.Scherrer:
Chronic eGFR slope over 3y
Pooled analysis of 820 patients planned!